Holen Sie sich die Stockscreener-App
25.00
5.77%
-1.53
Handel nachbörslich:
25.00
Schlusskurs vom Vortag:
$26.53
Offen:
$26.51
24-Stunden-Volumen:
118.87K
Relative Volume:
1.37
Marktkapitalisierung:
$890.24M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-13.49%
1M Leistung:
-6.26%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$24.18
$27.91
1-Wochen-Bereich:
$24.18
$29.40
52-Wochen-Spanne:
$24.10
$29.53
Ceribell Inc Stock (CBLL) Company Profile
Firmenname
Ceribell Inc
Sektor
Branche
Telefon
(800) 436-0826
Adresse
360 N. PASTORIA AVENUE, SUNNYVALE
Vergleichen Sie CBLL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| CBLL | 25.00 | 890.24M | 0 | 0 | 0 | 0.00 |
| ABT | 117.36 | 202.64B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 389.40 | 150.72B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 90.45 | 133.82B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 87.59 | 112.98B | 32.58B | 3.93B | 5.15B | 2.71 |
| EW | 69.89 | 40.52B | 6.60B | 4.16B | 490.10M | 2.34 |
Ceribell Inc Aktie (CBLL) Neueste Nachrichten
FY2024 EPS Estimates for CeriBell Decreased by William Blair - MarketBeat
William Blair Estimates CeriBell's Q1 Earnings (NASDAQ:CBLL) - MarketBeat
Ceribell revenue increases 48% to USD 17.2M in Q3 2024 - Medical Buyer
Ceribell, Inc. Reports Strong Q3 2024 Growth - Yahoo Finance
Ceribell price target raised to $31 from $30 at Canaccord - TipRanks
CeriBell (NASDAQ:CBLL) Price Target Raised to $31.00 at Canaccord Genuity Group - MarketBeat
CeriBell’s Quiet Period To End on November 20th (NASDAQ:CBLL) - Defense World
CeriBell's (NASDAQ:CBLL) Quiet Period To End on November 20th - MarketBeat
Ceribell Reports Third Quarter 2024 Financial Results - GlobeNewswire
CeriBell, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Ceribell Q3 Revenue Surges 48% to $17.2M, Expands Customer Base Post-IPO | CBLL Stock News - StockTitan
Ceribell Receives Authority to Operate from the U.S. Department of Veterans Affairs - GlobeNewswire
Ceribell Secures VA Authorization, Expands AI-Powered EEG Tech to Veterans Hospitals | CBLL Stock News - StockTitan
Q3 Earnings Estimate for CeriBell Issued By William Blair - Defense World
Brokerages Set CeriBell (NASDAQ:CBLL) PT at $31.00 - Defense World
Ceribell started with bullish ratings by J.P. Morgan, Canaccord - MSN
Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum - The Manila Times
FMR LLC Acquires New Stake in CeriBell Inc - GuruFocus.com
Ceribell initiated with a Buy at BofA on ‘differentiated AI algorithm’ - Yahoo Finance
Ceribell stock a buy as JPMorgan highlights disruptive tech in $3B seizure market - Investing.com Australia
Ceribell initiated with an Overweight at JPMorgan - MSN
Ceribell started with bullish ratings by J.P. Morgan, Canaccord (NASDAQ:CBLL) - Seeking Alpha
TD Cowen starts coverage on Ceribell stock with Buy, highlights innovative tech - Investing.com Canada
This Eaton Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
A&O Shearman advises on initial public offering of Ceribell, Inc. - A&O Shearman
Ceribell to Report Third Quarter 2024 Financial Results on November 12, 2024 - WV News
Ceribell’s stock soars 36% in trading debut after pricing IPO at top of range - MSN
Septerna Shares Jump 19% After IPO Shows Biotech Still Hot - Bloomberg
CeriBell Shares Rise 47% to Lead Trio of Life Sciences IPOs - MSN
CeriBell: An Interesting EEG Play Going Public (NASDAQ:CBLL) - Seeking Alpha
TPG GP A, LLC Acquires New Stake in CeriBell Inc - GuruFocus.com
Ceribell EEG system linked to improved patient outcomes - Investing.com India
Ceribell EEG system linked to improved patient outcomes By Investing.com - Investing.com Australia
Ceribell director Juliet Tammenoms Bakker buys $4.03m in stock By Investing.com - Investing.com Australia
Ceribell director Juliet Tammenoms Bakker buys $4.03m in stock - Investing.com
New Clinical Evidence Links Ceribell Point-of-Care EEG to Shorter Hospital Stays and Better Functional Outcomes Compared to Conventional EEG - PR Newswire
CeriBell closes upsized IPO - Medical Buyer
CeriBell, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares - PR Newswire
Ceribell CEO Jane Chao explains why now was the time for its upsized IPO - Fierce Biotech
Upstream Bio and Camp4 and Ceribell Transactions - William Blair
CeriBell (NASDAQ: CBLL) Stock Soars On Debut Trading: Here are Key Drivers - DRP Journal
Upstream Bio Leads Life Sciences IPOs With Upsized Listing - MSN
CeriBell, EEG developer, sees stock rally 35% following $180M IPO - MSN
CeriBell Goes Public in Rare Medical-Device IPO - The Wall Street Journal
Latham & Watkins Advises CeriBell on Upsized IPO - ILW.com
CeriBell IPO: Stock price soars as AI brain-monitoring headband maker debuts on Nasdaq - Fast Company
Upstream Bio Shares Rise 26% to Lead Burst of Life Sciences IPOs - MSN
Ceribell begins trading with upsized IPO - BioWorld Online
Finanzdaten der Ceribell Inc-Aktie (CBLL)
Es liegen keine Finanzdaten für Ceribell Inc (CBLL) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.38%
0.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):